The Best (and Worst) Super Bowl Commercial from Last Night
4 Real Estate Principles to Remember When Investing Online
France's Solar Roads Plan a Costly, Inefficient Boondoggle
Northair to Become Wholly-Owned Subsidiary of Kootenay Silver
Here What Amazon's Biggest Advantage Over Its Competitors Has Been
NanoViricides, Inc.'s (NNVC) Dr. Eugene Seymour sits down with Equities.com and talks about their role in the discovery and development of therapeutics for the treatment of viral infections.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2015 Equities
*All dates and time are being displayed in Eastern Standard Time (EST).